Report Detail

Other Global Newborn and Prenatal Genetic Testing Market Status and Forecast 2021-2027

  • RnM4336409
  • |
  • 23 July, 2021
  • |
  • Global
  • |
  • 117 Pages
  • |
  • GRD Survey
  • |
  • Other

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Newborn and Prenatal Genetic Testing Market Status and Forecast (2016-2027)
      • 1.3.2 Global Newborn and Prenatal Genetic Testing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Newborn and Prenatal Genetic Testing Supply by Company

    • 2.1 Global Newborn and Prenatal Genetic Testing Sales Value by Company
    • 2.2 Newborn and Prenatal Genetic Testing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Newborn and Prenatal Genetic Testing Market Status by Type

    • 3.1 Newborn and Prenatal Genetic Testing Type Introduction
      • 3.1.1 PCR
      • 3.1.2 FISH
      • 3.1.3 aCGH
      • 3.1.4 NIPT
      • 3.1.5 MSS
    • 3.2 Global Newborn and Prenatal Genetic Testing Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Newborn and Prenatal Genetic Testing Market Status by Application

    • 4.1 Newborn and Prenatal Genetic Testing Segment by Application
      • 4.1.1 Hospital
      • 4.1.2 Clinic
      • 4.1.3 Others
    • 4.2 Global Newborn and Prenatal Genetic Testing Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Newborn and Prenatal Genetic Testing Market Status by Region

    • 5.1 Global Newborn and Prenatal Genetic Testing Market by Region
    • 5.2 North America Newborn and Prenatal Genetic Testing Market Status
    • 5.3 Europe Newborn and Prenatal Genetic Testing Market Status
    • 5.4 Asia Pacific Newborn and Prenatal Genetic Testing Market Status
    • 5.5 Central & South America Newborn and Prenatal Genetic Testing Market Status
    • 5.6 Middle East & Africa Newborn and Prenatal Genetic Testing Market Status

    6 North America Newborn and Prenatal Genetic Testing Market Status

    • 6.1 North America Newborn and Prenatal Genetic Testing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Newborn and Prenatal Genetic Testing Market Status

    • 7.1 Europe Newborn and Prenatal Genetic Testing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Newborn and Prenatal Genetic Testing Market Status

    • 8.1 Asia Pacific Newborn and Prenatal Genetic Testing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Newborn and Prenatal Genetic Testing Market Status

    • 9.1 Central & South America Newborn and Prenatal Genetic Testing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Newborn and Prenatal Genetic Testing Market Status

    • 10.1 Middle East & Africa Newborn and Prenatal Genetic Testing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Newborn and Prenatal Genetic Testing Market Forecast by Type and by Application

    • 12.1 Global Newborn and Prenatal Genetic Testing Sales Value Forecast (2022-2027)
    • 12.2 Global Newborn and Prenatal Genetic Testing Forecast by Type
    • 12.3 Global Newborn and Prenatal Genetic Testing Forecast by Application

    13 Global Newborn and Prenatal Genetic Testing Market Forecast by Region/Country

    • 13.1 Global Newborn and Prenatal Genetic Testing Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Verinata Health
      • 14.1.1 Company Information
      • 14.1.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.1.3 Verinata Health Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sequenom, Inc.
      • 14.2.1 Company Information
      • 14.2.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.2.3 Sequenom, Inc. Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Perkin Elmer
      • 14.3.1 Company Information
      • 14.3.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.3.3 Perkin Elmer Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Natera, Inc.
      • 14.4.1 Company Information
      • 14.4.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.4.3 Natera, Inc. Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Illumina, Inc.
      • 14.5.1 Company Information
      • 14.5.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.5.3 Illumina, Inc. Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 CapitalBio MedLab
      • 14.6.1 Company Information
      • 14.6.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.6.3 CapitalBio MedLab Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Bio-Rad Laboratories, Inc.
      • 14.7.1 Company Information
      • 14.7.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.7.3 Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 BGI
      • 14.8.1 Company Information
      • 14.8.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.8.3 BGI Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Ariosa Diagnostics
      • 14.9.1 Company Information
      • 14.9.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.9.3 Ariosa Diagnostics Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Agilent Technologies, Inc.
      • 14.10.1 Company Information
      • 14.10.2 Newborn and Prenatal Genetic Testing Product Introduction
      • 14.10.3 Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Newborn and Prenatal Genetic Testing market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Newborn and Prenatal Genetic Testing industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Newborn and Prenatal Genetic Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Newborn and Prenatal Genetic Testing Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Newborn and Prenatal Genetic Testing market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Newborn and Prenatal Genetic Testing Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Newborn and Prenatal Genetic Testing industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      PCR
      FISH
      aCGH
      NIPT
      MSS

      Segmented by Application
      Hospital
      Clinic
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Verinata Health
      Sequenom, Inc.
      Perkin Elmer
      Natera, Inc.
      Illumina, Inc.
      CapitalBio MedLab
      Bio-Rad Laboratories, Inc.
      BGI
      Ariosa Diagnostics
      Agilent Technologies, Inc.


      Summary:
      Get latest Market Research Reports on Newborn and Prenatal Genetic Testing. Industry analysis & Market Report on Newborn and Prenatal Genetic Testing is a syndicated market report, published as Global Newborn and Prenatal Genetic Testing Market Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Newborn and Prenatal Genetic Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,172.42
      3,258.63
      4,344.84
      2,538.96
      3,808.44
      5,077.92
      330,482.00
      495,723.00
      660,964.00
      219,924.00
      329,886.00
      439,848.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report